Warburg Research Reiterates “€63.00” Price Target for Fresenius SE & Co KGaA (FRA:FRE)

Warburg Research set a €63.00 ($73.26) price objective on Fresenius SE & Co KGaA (FRA:FRE) in a research report report published on Thursday morning, Borsen Zeitung reports. The brokerage currently has a buy rating on the stock.

Several other analysts have also recently issued reports on FRE. Deutsche Bank set a €65.00 ($75.58) price objective on shares of Fresenius SE & Co KGaA and gave the company a buy rating in a research note on Wednesday, February 12th. UBS Group set a €47.00 ($54.65) price objective on shares of Fresenius SE & Co KGaA and gave the company a neutral rating in a research note on Monday, February 3rd. DZ Bank reaffirmed a buy rating on shares of Fresenius SE & Co KGaA in a research note on Friday, January 31st. Nord/LB set a €58.00 ($67.44) price objective on shares of Fresenius SE & Co KGaA and gave the company a buy rating in a research note on Tuesday, October 29th. Finally, JPMorgan Chase & Co. set a €59.40 ($69.07) price objective on shares of Fresenius SE & Co KGaA and gave the company a buy rating in a research note on Thursday. Eight equities research analysts have rated the stock with a hold rating and eight have given a buy rating to the company’s stock. The company has a consensus rating of Buy and a consensus price target of €56.37 ($65.54).

FRE stock opened at €49.66 ($57.74) on Thursday. The firm has a 50-day simple moving average of €48.56 and a 200-day simple moving average of €46.63. Fresenius SE & Co KGaA has a 52 week low of €60.16 ($69.95) and a 52 week high of €80.00 ($93.02).

About Fresenius SE & Co KGaA

Fresenius SE & Co KGaA, a health care group, provides products and services for dialysis, hospitals, and outpatient medical care worldwide. The company operates through Fresenius Medical Care, Fresenius Kabi, Fresenius Helios, and Fresenius Vamed segments. The Fresenius Medical Care segment offers products for patients with chronic kidney failure.

Recommended Story: How Do You Make Money With Penny Stocks?

Analyst Recommendations for Fresenius SE & Co KGaA (FRA:FRE)

Receive News & Ratings for Fresenius SE & Co KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fresenius SE & Co KGaA and related companies with MarketBeat.com's FREE daily email newsletter.